Search results
Cosmo Feilding Mellen CEO Cosmo is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances in order to help patients in need.
View Cosmo Feilding Mellen’s profile on LinkedIn, a professional community of 1 billion members. Experience: Beckley Psytech · Education: University of Oxford · Location: United Kingdom ·...
- 153
- Beckley Psytech
- 441
- United Kingdom
- A Delayed Brunch
- Mystic Healing
- Like Mother, Like Son
- The Religion of Science
- A Hell of A Life
Trying to conduct a choreographed interview over brunch with Feilding is a bit like trying to catch a hurricane in a fishing net. Once she gets going on a subject it’s easy to forget that there’s coffee to be drunk and food to be eaten. When I enter Beckley Park’s dining room I notice a photo book of the Chauvet Cave paintings,prehistoric artwork t...
So, how are the mystical experiences that Feilding is telling me about relevant to Beckley Psytech’s business model? She points me to the results of a 2018 studyconducted by Imperial College London in partnership with The Beckley Foundation, a non-profit psychedelic research organisation founded by Feilding in 1998. The study saw 20 patients with s...
Dressed in a green velvet blazer and bejewelled belt, speaking in the clipped and articulate English of the British upper classes, Feilding lives up to her reputation of the “eccentric aristocrat”. Feilding-Mellen, meanwhile, is the more modern face of Beckley Psytech and affably plays the role of reining in his mother’s obvious personal passion fo...
These aren’t the only big names from institutional science that have thrown their weight behind the promise of psychedelic therapy. Feilding has previously collaborated with researchers like David Nutt of Imperial College London (and formerly the UK government’s chief adviser on drug misuse) and Colin Blakemore of Oxford University on a number of s...
The fact that Beckley Psytech is now attracting investment to try and bring psychedelics into mainstream medicine is evidently a source of great satisfaction for Feilding. “It feels very good,” she says with a smile. “We’ve reached the foothills, but it’s taken 50 years to get there.” That 50-year journey is one that’s taken her from a family life ...
Feb 7, 2024 · I’m about to have lunch with pioneering drug campaigner Amanda Feilding, 81, and her youngest son Cosmo Feilding-Mellen, 39; between them they run two of the three arms of the Beckley...
Cosmo Feilding Mellen is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances. In 2019, he co-founded Beckley Psytech, a private, clinical-stage biotechnology company on a mission to develop novel, rapid-acting, short-duration psychedelic medicines that address the huge unmet need of those ...
Cosmo Feilding Mellen. Cosmo is CEO at Beckley Psytech and a drug development entrepreneur dedicated to unlocking the medical potential psychoactive substances, in order to help patients in need.
Aug 22, 2021 · In the run-up to the funding announcement, PSYCH spoke with the UK-based organisation’s CEO Cosmo Feilding Mellen. We sought to raise US$50 million to support our development programmes, and the response was incredibly positive.
